{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:05:46Z","timestamp":1761663946999,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.anpedi.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T21:38:15Z","timestamp":1609191495000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impacto de faster aspart sobre el control gluc\u00e9mico en ni\u00f1os y adolescentes con diabetes tipo 1 en tratamiento con un sistema integrado"],"prefix":"10.1016","volume":"95","author":[{"given":"Jes\u00fas","family":"Gonz\u00e1lez de Buitrago Amigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gonz\u00e1lez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"D\u00edaz Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Fern\u00e1ndez Llamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luz","family":"Tejado Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge M.","family":"de Nicol\u00e1s Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ferrer Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2020.11.002_bib0200","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(94)70190-3","article-title":"Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial","volume":"125","author":"Diabetes Control and Complications Trial Research Group","year":"1994","journal-title":"J Pediatr."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/diacare.22.1.99","article-title":"Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort","volume":"22","author":"Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group","year":"1999","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents and young adults with diabetes","volume":"19","author":"DiMeglio","year":"2018","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/pedi.12718","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes","volume":"19","author":"Danne","year":"2018","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-015-3790-6","article-title":"Use of insulin pumptherapy in children and adolescents wityh type 1 diabetes and its impact on metabolic control: comparison of results from three large transatlantic paediatric registries","volume":"59","author":"Sherr","year":"2016","journal-title":"Diabetologia."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0235","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","article-title":"Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continous subcutaneous insulin infusion versus multiple daily injections","volume":"94","author":"Fatourechi","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0240","first-page":"29","article-title":"Hiperglucemia posprandrial y variabilidad gluc\u00e9mica: nuevos objetivos de control de la diabetes","volume":"26","author":"Ampudia-Blasco","year":"2010","journal-title":"Av Diabetol."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0245","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.2337\/dc20-S013","article-title":"Children and Adolescents: Standards of Medical Care in Diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0250","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/dc11-s206","article-title":"Postprandial hyperglycemia and glycemic variability: should we care?","volume":"34","author":"Standl","year":"2011","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0260","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/dme.13116","article-title":"One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel study of glucose intolerance, obesity and hypertension","volume":"33","author":"Bergman","year":"2016","journal-title":"Diabet Med."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0265","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.290.4.486","article-title":"Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial","volume":"290","author":"Chiasson","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0270","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMoa1001122","article-title":"Effect of nateglinide on the incidence of diabetes and cardiovascular events","volume":"362","author":"Holman","year":"2010","journal-title":"N England J Med."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/2042018818763247","article-title":"Pharmacotherapy of type 1 diabetes in children and adolescents: more than insulin?","volume":"9","author":"Biester","year":"2018","journal-title":"Ther Adv Endocrinol Metab."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0280","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/193229681200600402","article-title":"Ultrafast-acting insulins: state of the art","volume":"6","author":"Heinemann","year":"2012","journal-title":"J Diabetes Sci Technol."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/dom.13052","article-title":"The challenges of achieving postprandial glucose control using closed-loops systems in patients with type 1 diabetes","volume":"20","author":"Gingras","year":"2018","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11095-019-2578-7","article-title":"Elucidating the mechanism of absorption of fast-acting insulin aspart: the role of niacinamide","volume":"36","author":"Kildegaard","year":"2019","journal-title":"Pharm Res."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0295","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40262-017-0514-8","article-title":"A pooled analysis of clinical pharmacology trials investigating the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in adults with type 1 diabetes","volume":"56","author":"Heise","year":"2017","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0300","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/pedi.12506","article-title":"Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in chidren and adolescent with type 1 diabetes mellitus","volume":"18","author":"Fath","year":"2017","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0305","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/dom.12803","article-title":"Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continous subcutaneous insulin infusion: a randomized, double-blind, crossover trial","volume":"19","author":"Heise","year":"2017","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0310","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2337\/dc19-0009","article-title":"Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both in combination with insulin degludec, in children and adolescents with type 1 diabetes: the onset 7 trial","volume":"42","author":"Bode","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0315","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0395","first-page":"552","article-title":"Estudio transversal espa\u00f1ol de crecimiento 2008","volume":"68","author":"Carrascosa","year":"2008","journal-title":"Parte II: valores de talla, peso e \u00edndice de masa corporal desde el nacimiento a la talla adulta. An Pediatr."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0325","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc16-1771","article-title":"Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1)","volume":"40","author":"Russell-Jones","year":"2017","journal-title":"Diabetes Care."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0330","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dom.13610","article-title":"A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)","volume":"21","author":"Klonoff","year":"2019","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/dia.2016.0350","article-title":"Improved postprandial glycemic control with faster-acting insulin aspart in patients with type 1 diabetes using continous subcutaneous insulin infusion","volume":"19","author":"Bode","year":"2017","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0340","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The relationships between time in range, hyperglycemia metrics and hbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1C to time-in-range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0350","first-page":"1","article-title":"Use of fast-acting insulin aspart in insulin pump therapy in clinical practice","author":"Evans","year":"2019","journal-title":"Diabetes Obes Metab."},{"journal-title":"Summary of the European Public Assessment Report on Fiasp","year":"2017","author":"European Medicines Agency","key":"10.1016\/j.anpedi.2020.11.002_bib0355"},{"key":"10.1016\/j.anpedi.2020.11.002_bib0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/dia.2018.0295","article-title":"Insulin bolus administration in insulin pump therapy: effect of bolus delivery speed on insulin absorption from subcutaneous tissue","volume":"21","author":"Regittnig","year":"2019","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0365","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1111\/dom.13545","article-title":"Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial","volume":"20","author":"Buse","year":"2018","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0370","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1932296816663747","article-title":"Recommendtions for using real-time continous glucose monitoring (rtCGM) for insulin adjustments in type 1 diabetes","volume":"11","author":"Pettus","year":"2017","journal-title":"J Diabetes Sci Technol."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0375","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1210\/js.2017-00389","article-title":"A practical approach using trend arrows on the Dexcom G5 CGM system to manage children and adolescents with diabetes","volume":"1","author":"Laffel","year":"2017","journal-title":"J Endocr Soc."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0380","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1932296817730375","article-title":"Investigation of pump compatibility of fast-acting insulin aspart in continuous subcutaneous insulin infusion in subjects with type 1 diabetes","volume":"12","author":"Zijlstra","year":"2018","journal-title":"J Diabetes Sci Technol."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0385","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-8227(98)00132-6","article-title":"Injection-meal interval: recommendations of diabetologists and how patients handle it","volume":"43","author":"Overmann","year":"1999","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.anpedi.2020.11.002_bib0390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1034\/j.1399-5448.2002.30103.x","article-title":"Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups","volume":"3","author":"Ahern","year":"2002","journal-title":"Pediatr Diabetes."}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403320304811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403320304811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:35Z","timestamp":1761663155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403320304811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1695403320304811"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2020.11.002","relation":{},"ISSN":["1695-4033"],"issn-type":[{"type":"print","value":"1695-4033"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacto de faster aspart sobre el control gluc\u00e9mico en ni\u00f1os y adolescentes con diabetes tipo 1 en tratamiento con un sistema integrado","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}